U.O.C. Ematologia, U.O.S. Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pediatrics, Yale University School of Medicine, New Haven, CT.
Am J Hematol. 2020 May;95(5):472-482. doi: 10.1002/ajh.25753. Epub 2020 Mar 6.
Pyruvate kinase (PK) deficiency is a rare recessive congenital hemolytic anemia caused by mutations in the PKLR gene. This study reports the molecular features of 257 patients enrolled in the PKD Natural History Study. Of the 127 different pathogenic variants detected, 84 were missense and 43 non-missense, including 20 stop-gain, 11 affecting splicing, five large deletions, four in-frame indels, and three promoter variants. Within the 177 unrelated patients, 35 were homozygous and 142 compound heterozygous (77 for two missense, 48 for one missense and one non-missense, and 17 for two non-missense variants); the two most frequent mutations were p.R510Q in 23% and p.R486W in 9% of mutated alleles. Fifty-five (21%) patients were found to have at least one previously unreported variant with 45 newly described mutations. Patients with two non-missense mutations had lower hemoglobin levels, higher numbers of lifetime transfusions, and higher rates of complications including iron overload, extramedullary hematopoiesis, and pulmonary hypertension. Rare severe complications, including lower extremity ulcerations and hepatic failure, were seen more frequently in patients with non-missense mutations or with missense mutations characterized by severe protein instability. The PKLR genotype did not correlate with the frequency of complications in utero or in the newborn period. With ICCs ranging from 0.4 to 0.61, about the same degree of clinical similarity exists within siblings as it does between siblings, in terms of hemoglobin, total bilirubin, splenectomy status, and cholecystectomy status. Pregnancy outcomes were similar across genotypes in PK deficient women. This report confirms the wide genetic heterogeneity of PK deficiency.
丙酮酸激酶(PK)缺乏症是一种罕见的常染色体隐性遗传性溶血性贫血,由 PKLR 基因突变引起。本研究报告了参与 PKD 自然史研究的 257 例患者的分子特征。在检测到的 127 种不同的致病性变异中,84 种为错义,43 种为非错义,包括 20 种无义突变、11 种影响剪接、5 种大片段缺失、4 种框内缺失和 3 种启动子变异。在 177 例无关患者中,35 例为纯合子,142 例为复合杂合子(77 例为两种错义,48 例为一种错义加一种非错义,17 例为两种非错义);最常见的两种突变是 p.R510Q(占突变等位基因的 23%)和 p.R486W(占 9%)。55 例(21%)患者至少有一种以前未报道的变异,其中 45 种为新描述的突变。携带两种非错义突变的患者血红蛋白水平较低,一生中需要输血的次数较多,并发症发生率较高,包括铁过载、骨髓外造血和肺动脉高压。非错义突变或具有严重蛋白不稳定特征的错义突变患者更容易出现罕见的严重并发症,包括下肢溃疡和肝功能衰竭。PKLR 基因型与宫内或新生儿期并发症的发生频率无关。ICCs 范围为 0.4 至 0.61,兄弟姐妹之间的血红蛋白、总胆红素、脾切除术状态和胆囊切除术状态的临床相似性与兄弟姐妹之间的相似性大致相同。PK 缺乏症女性的妊娠结局在不同基因型之间相似。本报告证实了 PK 缺乏症的广泛遗传异质性。